Kinex Pharmaceuticals Management

About Us Team Pipeline News Contact Us Home
Kinex raises more than $3 million in equity financing

Kinex Co-Founder Appointed to NYBA Board

Kinex Awarded US Patent

Start of Clinical Trial for KX2-391

KX2-391 Enters Phase 1 Clinical Trials for Oncology

More headlines ...

Management Team


Lyn Dyster, Ph.D.
Vice President
Research Operations
ldyster@kinexpharma.com

Dr. Dyster is a scientist/entrepreneur and a co-founder of Kinex. She is a graduate of Washington and Jefferson College and later earned a Ph.D. in biochemistry from the University of Buffalo. Following post-doctoral studies, she spent several years in the biotechnology field at Cellular Products, Inc. (Buffalo, NY) and was responsible for the development of a number of products relating to the molecular diagnoses of infectious disease agents.

Dr. Dyster was a founder of a previous biotech start-up and brings entrepreneurial and business management expertise to Kinex.